Insulin

FTC Sues Big Three PBMs for Artificially Inflating Insulin Prices Through Rebate Schemes

2024-09-20 00:00:00 +0000 UTC | Importance: 9/10

The Federal Trade Commission filed an administrative antitrust complaint against the three largest pharmacy benefit managers—CVS Caremark, Express Scripts (Cigna), and OptumRx (UnitedHealth)—and their affiliated group purchasing organizations, charging them with anticompetitive and unfair practices …

Federal Trade Commission Lina Khan CVS Caremark Express Scripts OptumRx +3 more healthcare pbm pharmacy antitrust ftc +3 more

Senate Hearing Exposes PBM Insulin Profiteering: 75% of Sales Go to Rebates and Fees

2023-05-10 00:00:00 +0000 UTC | Importance: 9/10

The Senate Health, Education, Labor, and Pensions (HELP) Committee held a historic hearing bringing together CEOs of major insulin manufacturers (Eli Lilly, Novo Nordisk, Sanofi) and executives from the three largest PBMs (CVS Caremark, Express Scripts, OptumRx) to examine soaring insulin prices. …

Bernie Sanders Senate HELP Committee Lars Fruergaard Jorgensen Paul Hudson Heather Cianfrocco +6 more healthcare pbm pharmacy insulin drug-pricing +2 more